Breaking Business News | Breaking business news AM | Breaking Business News PM

Here’s why JPMorgan just downgraded Moderna stock, despite COVID vaccine mania

20 Jul 2020

JPMorgan has downgraded shares in COVID-19 vaccine maker Moderna’s stock over valuation concerns. The drop is from overweight to neutral.

JPMorgan has downgraded shares in COVID-19 vaccine maker Moderna’s stock over valuation concerns.


Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.

Download